Genetics & Epigenetics Library
Every article, presentation, spotlight, and news item we've tagged to Genetics & Epigenetics.
Showing 121–144 of 176
Whole Genome Sequencing at Clinical Grade for $599
Human Longevity Inc. launched Genomics for All, a $599 whole genome sequencing test that delivers clinical-grade results via AI interpretation without requiring a clinic visit. The product identifies disease risk across 10,000+ genetic variants, flags medication response markers, and provides AI-powered reanalysis as new research emerges.
SIRT6 centenarian variant activates cellular aging pathways
Genflow Biosciences is advancing SIRT6 gene therapy targeting age-related disease and metabolic dysfunction, with preclinical validation in aged dogs and planned human trials. SIRT6 activation represents a direct intervention in cellular aging pathways known to regulate energy metabolism, stress response, and tissue regeneration.
Sex-specific biological aging: 21-system assessment beyond composite scores
Generation Lab has introduced SystemAge, an at-home biological age assessment platform that evaluates aging across 21 body systems with sex-specific calibration, moving away from single composite scores. The approach incorporates lifestyle factors—walking quality, travel-related stress, sleep adaptation—as measurable drivers of aging rate, grounding longevity testing in modifiable behaviors rather than static biomarker snapshots alone.
Epigenetic reprogramming reverses aging at cellular level
Epigenetic reprogramming represents a shift from static aging theories to a dynamic model where gene expression patterns—not DNA sequence itself—drive aging processes and can be therapeutically reversed. This reframes longevity interventions from inevitable decline management to targeted restoration of youthful cellular states.
Whole Genome Sequencing Redefines Preventive Health at $599
Clinical-grade whole genome sequencing at $599 represents a threshold moment for genomics in preventive healthcare, moving from exclusive research tool to mass-market accessibility. The service sequences all 6.4 billion DNA base pairs and delivers continuously updated interpretations as scientific understanding evolves, potentially shifting how individuals decode inherited disease risks and medication responses.
Traditional Risk Factors Outperform Epigenetic Clocks
Traditional risk factors—age, sex, smoking, alcohol consumption, waist-to-hip ratio, and BMI—predict chronic disease incidence more accurately than epigenetic clocks in middle-aged adults over 7–9 years. This finding challenges the clinical utility of epigenetic aging biomarkers without demonstrated incremental value over conventional assessment.
Avaí Bio–Austrianova’s longevity protein program enters production
Avaí Bio and Austrianova have begun GMP-compliant production of a Master Cell Bank for genetically modified cells engineered to overexpress α-Klotho, a protein associated with improved cognitive resilience and organ function in aging. This transition from research to scalable manufacturing represents a critical step toward clinical cell therapy delivery for age-related disease.
Genetic Testing Strategy: When Results Drive Real Health Changes
Genetic testing offers measurable clinical value when deployed strategically for risk stratification and actionable intervention, but its utility depends entirely on test selection, clinical context, and thoughtful interpretation of results. Random testing without a clear hypothesis or intervention pathway generates noise rather than insight.
One-time gene therapy targets metabolic reset
Fractyl Health has received regulatory approval to initiate Phase 1/2 trials of RJVA-001, a single-administration gene therapy designed to enable patients' own cells to produce GLP-1 indefinitely. This represents a shift toward durable metabolic interventions that require one-time dosing rather than ongoing pharmaceutical management.
Organ-specific aging clocks detect system decline before whole-body decline
Biological aging clocks have evolved from whole-body measures to organ-specific readouts that integrate molecular and imaging data, revealing that organs age at different rates within the same individual. This granularity shifts how we detect and potentially intervene in age-related decline across physiological systems.
Klotho Therapy Gains Direct Researcher-Patient Dialogue Model
GARM Clinic convened three leading Klotho researchers with 22 participants receiving a Klotho-based intervention, creating direct dialogue between scientists and patients—a rare model in longevity medicine that reflects shifting expectations for transparency and engagement in therapeutic development.
Healthy Eating Index, Epigenetic Age Acceleration and Mortality Risk in US Adults
Higher diet quality correlates with slower epigenetic aging and reduced mortality risk in two large U.S. cohorts, with epigenetic age acceleration (GrimAgeEAA) explaining approximately 44% of the diet-mortality association in one cohort. The relationship is partially confounded by physical activity and integrated lifestyle factors, indicating that diet operates within a broader system of behavioral and biological aging pathways rather than in isolation.
Garm adds Klotho to cell and gene therapy platform in Roatan
Garm LLC expanded its non-permanent plasmid gene therapy platform to include Klotho alongside existing follistatin and VEGF therapies, targeting mitochondrial function, inflammation reduction, oxidative stress management, and metabolic aging. The platform operates in Roatan, Honduras, positioning itself as a personalized longevity intervention without permanent genetic modification.
Klotho Cell Therapy Restores Aging Protein via Encapsulation
Avaí Bio will present clinical data on an encapsulated cell therapy designed to restore circulating α-Klotho, a protein implicated in aging and metabolic regulation. The approach uses Austrianova's Cell-in-a-Box technology to sustain Klotho production, addressing a mechanism that declines with age and correlates with multiple age-related pathologies.
Sex-specific aging detection reveals organ system trajectories
Generation Lab's SystemAge 2.1 introduces sex-specific biological age assessments, recognizing that aging follows distinct trajectories in men and women. This represents a shift from single-model testing toward personalized interpretation of how different organ systems age, enabling more precise clinical intervention timing.
Histone Deacetylase 9 Gene Deletion Ameliorates Aging‐Related Adipose Tissue Senescence and Mitochondrial Dysfunction in Mice
HDAC9 gene deletion in mice reduces age-related fat tissue senescence and restores mitochondrial function through upregulation of thiosulfate sulfurtransferase (TST), a protein whose decline contributes to metabolic dysfunction during aging. This identifies HDAC9 as a druggable epigenetic target for preserving adipose tissue health.
Microcap produces anti-aging protein from encapsulated cells
Klothonova is developing an encapsulated cell therapy designed to restore circulating α-Klotho, a protein that declines with age and influences cardiovascular, renal, and cognitive function. The approach uses genetically modified cells housed in a biocompatible capsule to sustainably produce the protein, addressing a mechanism implicated in multiple age-related conditions.
AI-driven aging therapies target root biology over symptoms
AI-driven drug discovery is shifting medicine from treating downstream diseases to targeting aging biology itself, enabling personalized interventions tailored to individual biological signatures. This represents a fundamental reconceptualization of the therapeutic development process—from disease-specific pipelines to restoration of youthful cellular function.
Host Oxidative Response Capacity Determines Longevity Outcomes of Microbial Interventions
Host genetic capacity to manage oxidative stress determines whether microbiota interventions extend or shorten lifespan. Individuals with genetic variants affecting redox buffering show accelerated aging when exposed to the same microbial signals that promote longevity in genetically robust hosts. This finding establishes oxidative stress management as the critical variable in microbiome-driven aging outcomes.
Sirtuin-FOXO Axis Sustains Mitochondrial Repair and Lifespan
Age-related decline in the sirtuin AcSirt2 impairs mitochondrial quality control in honey bees, while restoring this protein activates a FOXO-dependent pathway that clears damaged mitochondria, reduces oxidative stress, and extends lifespan. This mechanism identifies a conserved axis for mitochondrial homeostasis relevant to aging across species.
Age-Associated Metabolites: AI Framework for Precision Monitoring
Immorta Bio and collaborators published a framework integrating multi-omics, artificial intelligence, and digital twins to operationalize precision medicine at scale. Analysis of metabolomic data from over 2,000 individuals identified nine age-associated metabolites, establishing a foundation for continuous, data-driven health monitoring and intervention.
Alpha-Klotho Manufacturing Milestone Clears Path to Clinic
Avaí Bio has completed a Good Manufacturing Practice Master Cell Bank for alpha-Klotho therapy, establishing the standardized cellular foundation required for consistent clinical-scale production. This manufacturing milestone addresses a critical bottleneck in longevity biotechnology: translating promising discoveries into reliably produced treatments.
Some Researchers Choose Replacement Over Repair in Aging
Replacement-based interventions—substituting damaged cells, tissues, organs, and physiological systems with biological or synthetic alternatives—are emerging as a pragmatic complement to endogenous repair strategies in aging research. Multiple research organizations are advancing clinical applications ranging from stem cell therapies for structural injuries to bioprinted organs and genetic replacements derived from long-lived species.
Vitamin K2 Extends Lifespan by Alleviating Mitochondrial Stress via the JNK‐1/SIR‐2.1/DAF‐16 Signaling Axis in Caenorhabditis elegans
Vitamin K2 at optimal concentrations (5 μM) extends lifespan in C. elegans by activating a signaling pathway that protects mitochondria from oxidative stress, maintains ATP production, and enhances cellular stress resistance. This mechanism operates through preservation of mitochondrial function and reduction of reactive oxygen species accumulation.